Concepedia

The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study

Yasuo Hozumi, Kimito Suemasu, Hidehiro Takei, Tomohiko Aihara, Megumi Takehara, Tsuyoshi Saito, Shozo Ohsumi, Norikazu Masuda, Yasuo Ohashi

Annals of Oncology · 2011 · 57 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

, , +6

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

, , +13

Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer

Richard R. Love, Richard B. Mazess, Howard S. Barden et al. · New England Journal of Medicine · 1992 · 1.1K citations · Full text

, , +17

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

R. Charles Coombes, CF Snowdon, Robert Paridaens et al. · The Lancet · 2007 · 909 citations

, , +4

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer

Cancer · 2003 · 858 citations

, , +15